Canada #32 >>>/qresearch/16309893

A Hidden Document Shows Obama Met Dr. Tedros and Terrorist Leaders of Ethiopia in 2014 – Then In 2017 Tedros Elected Head of WHO

Document

https://web.archive.org/web/20200519233050/http://hornofafrica.de/ethiopia-from-tigray-peoples-liberation-front/

A document that has now been deleted from the Internet shows Barack Obama meeting with Dr. Tedros of Ethiopia and other terrorist leaders of that country. A few years later Dr. Tedros was elected to lead the World Health Organization (WHO).

In March 2020 the China coronavirus was attacking and terrorizing the world. It was at this time that we learned about the General Secretary of the WHO’s past.

TGP reported that Dr. Tedros was fourth in line of leadership in Ethiopia. We also learned that the leadership of Ethiopia was a terrorist regime. This regime and China were closely connected as well. China was happy to deal with the regime and in turn take advantage of the country’s resources and people.

Tedros and his Ethiopian leadership colleagues were connected to the worst kind of abuse.

We have identified a document that is no longer available on the Internet but is available on the wayback machine. This document shows Obama in a meeting with Ethiopian leaders in 2014. The article is titled “The US Cannot save Ethiopia from Tigray-Peoples-Liberation-Front”. The cover of the article shows Barack Obama, Susan Rice, John Kerry, and others meeting with Dr. Tedros and other leaders of the Ethiopian terrorist regime. For some reason, this article has been deleted from the Internet.

Continued at source:

https://www.thegatewaypundit.com/2022/05/hidden-document-shows-obama-met-dr-tedros-terrorist-leaders-ethiopia-2014-2017-tedros-elected-head/

Canada #32 >>>/qresearch/16310561

Fauci Delivered $100MM Of NIAID Funds To A Company Called Bavarian Nordic To Create This Monkeypox Vaccine

Summaries of health policy coverage from major news organizations

Wall Street Journal Examines NIH Funding For Anti-Bioterrorism Medications, Vaccines

The Wall Street Journal on Tuesday examined the role Anthony Fauci, director of the NIH National Institute of Allergy and Infectious Diseases, has played since the Sept. 11, 2001, attacks to direct funding to drug companies to produce biodefense medicines. After the terrorist and anthrax attacks, Fauci argued that NIAID was “well-suited to receive new funds for biodefense,” and the agency’s biodefense-related funding rose from $42 million annually in 2001 to about $1.2 billion in 2003 and $1.7 billion in 2005, the Journal reports. Fauci decided to “fund companies on a large scale” and currently directs $500 million to $600 million annually for new bioterrorism product development, according to the Journal. Last year HHS was authorized by Congress to spend $5.6 billion over 10 years on biodefense drugs. According to the Journal, Fauci’s goal is to prepare companies to bid on contracts under Project BioShield, which is managed by HHS. His strategy is to “place bets on multiple companies in the hopes of hitting the jackpot and to dole out NIH’s money in multiple rounds, using milestones to gauge progress,” the Journal reports. For instance, Fauci led NIH in an effort to develop a new anthrax vaccine, awarding $100 million in two funding rounds to VaxGen and about $80 million in two rounds to Avecia Group to prepare them to compete for a federal contract to develop a new anthrax vaccine for Project BioShield. BioPort, maker of an existing anthrax vaccine, protested NIH’s decision to ban makers of the older-generation vaccine from bidding and after launching a public relations campaign received a $122 million contract to produce the older vaccine. Ultimately, HHS awarded VaxGen the entire $877 million BioShield contract, but the company has “stumbled and its vaccine is almost a year late,” according to the Journal. In another instance, Fauci gave about $100 million each to Bavarian Nordic and Acambis for research on a smallpox vaccine in preparation for a BioShield contract to be awarded in 2006. NIH officials gave Acambis samples of the modified smallpox virus used by Bavarian, prompting Bavarian to file a civil lawsuit and a patent complaint against Acambis. Bavarian did not sue NIH, however, and Acambis maintains that it received the virus without restrictions on its use, the Journal reports. Fauci could not comment on the case.

Continued at source:

https://breaking-news.ca/fauci-delivered-100mm-of-niaid-funds-to-a-company-called-bavarian-nordic-to-create-this-monkeypox-vaccine/